Zydus Lifesciences extends Sterling Biotech API business acquisition deadline to Sept 30

Shares of Zydus Lifesciences Ltd ended at ₹1,121.45, up by ₹1.81, or 19.95%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *